US PATENT SUBCLASS 530 / 381-- .~.~ Blood coagulation factors and fibrin, e.g., thromboplastin, etc.

US PATENT SUBCLASS 530 / 381
.~.~ Blood coagulation factors and fibrin, e.g., thromboplastin, etc.

Current as of: June, 1999
Click HD for Main Headings
Click for All Classes

Internet Version by PATENTEC © 1999 Terms of Use

530 /	HD	CHEMISTRY: NATURAL RESINS OR DERIVATIVES; PEPTIDES OR PROTEINS; LIGNINS OR REACTION PRODUCTS THEREOF

350	DF	PROTEINS, I.E., MORE THAN 100 AMINO ACID RESIDUES {14}
380	DF	.~ Blood proteins or globulins, e.g., proteoglycans, platelet factor 4, thyroglobulin, thyroxine, etc. {3}
381		.~.~ Blood coagulation factors and fibrin, e.g., thromboplastin, etc. {3}
382	DF	.~.~.~> Fibrin or fibrin intermediates, e.g., fibrinogen, etc.
383	DF	.~.~.~> Blood coagulation factor VIII, AHF
384	DF	.~.~.~> Blood coagulation factor II or factor II + VII + IX + X, i.e., prothrombin complex or factor

DEFINITION

Classification: 530/381

Blood coagulation factors and fibrin, e.g., thromboplastin, etc.:

(under subclass 350) Proteins identified as Blood Coagulation Factors or fibrin and compounds derived from these by addition to or deletion of parts of polypeptide structure.

(1) Note. Important blood clotting factors include:

International designation

Name

I

Fibrinogen

II

Prothrombin IIa

Thrombia

III

Tissue thromboplastin

V and VI

Proaccelerin, accelerat or globulin

VII

Proconvertin

VIII

Antihemophilic globulin (AHG)

IX

Christmas Factor, plasma thromboplastin component (PTC)

X

Stuart-Prower factor, autoprothrombin III

IX

Plasma thromboplastin antecedent (PTA)

XII

Hagemann Factor

XIII

Fibrin-stabilizing factor

(2) Note. Examples, Blood Coagulation Factor XIII, Laki-Lorand Factor, Fibrin-stabilizing Factor, Fibrinase.

(3) Note. CA Registry Number of unmodified form: [figure]

SEE OR SEARCH CLASS 516, Colloid Systems and Wetting Agents; Subcombinations Thereof; Processes of Making, Stabilizing, Breaking, or Inhibiting,

98+, for colloid systems of continuous or semicontinuous solid phase with discontinuous liquid phase (gels, pastes, flocs, coagulates) or agents for such systems or making or stabilizing such systems or agents, when generically claimed or when there is hierarchically superior provision in the USPC for the specifically claimed art.